Interventions to improve adherence to lipid lowering medication

作者: Mieke L van Driel , Michael D Morledge , Robin Ulep , Johnathon P Shaffer , Philippa Davies

DOI: 10.1002/14651858.CD004371.PUB4

关键词: Clinical trialReporting biasAdverse effectSelection biasPhysical therapyPharmacistMedicineSystematic reviewOdds ratioPsychological intervention

摘要: Background Lipid-lowering drugs are widely underused, despite strong evidence indicating they improve cardiovascular end points. Poor patient adherence to a medication regimen can affect the success of lipid-lowering treatment. Objectives To assess effects interventions aimed at improving drugs, focusing on measures and clinical outcomes. Search methods We searched Cochrane Central Register Controlled Trials (CENTRAL), MEDLINE, Embase, PsycINFO CINAHL up 3 February 2016, trials registers (ANZCTR ClinicalTrials.gov) 27 July 2016. We applied no language restrictions. Selection criteria We evaluated randomised controlled adherence-enhancing for in adults an ambulatory setting with variety measurable outcomes, such as treatment changes serum lipid levels. Two teams review authors independently selected studies. Data collection analysis Three extracted assessed data, following criteria outlined by Handbook Systematic Reviews Interventions. quality using GRADEPro. Main results For this updated review, we added 24 new studies meeting eligibility 11 from prior updates. have therefore included 35 studies, randomising 925,171 participants. Seven including 11,204 individuals compared rates those intensification care intervention (e.g. electronic reminders, pharmacist-led interventions, healthcare professional education patients) versus usual over short term (six months or less), were pooled meta-analysis. Participants group had better than receiving (odds ratio (OR) 1.93, 95% confidence interval (CI) 1.29 2.88; 7 studies; participants; moderate-quality evidence). A separate analysis also showed improvements long-term (more six months) (OR 2.87, CI 1.91 4.29; 663 high-quality Analyses effect total cholesterol LDL-cholesterol levels positive intensified both short- follow-up. Over term, decreased mean 17.15 mg/dL (95% 1.17 33.14; 4 430 low-quality evidence) 19.51 8.51 30.51; 333 long 17.57 14.95 20.19; 2 127 Included did not report usable data health outcome indications, adverse costs/resource use, so could pool these outcomes. each study bias methods described In general, risk assessment revealed low selection bias, attrition reporting bias. There was unclear relating blinding most studies. Authors' conclusions The our demonstrates that improves adherence, well Healthcare systems which implement team-based may be successful medicines.

参考文章(135)
José M Castellano, Ginés Sanz, José L Peñalvo, Sameer Bansilal, Antonio Fernández-Ortiz, Luz Alvarez, Luis Guzmán, Juan Carlos Linares, Fernando García, Fabiana D’Aniello, Joan Albert Arnáiz, Sara Varea, Felipe Martínez, Alberto Lorenzatti, Iñaki Imaz, Luis M Sánchez-Gómez, Maria Carla Roncaglioni, Marta Baviera, Sidney C Smith, Kathryn Taubert, Stuart Pocock, Carlos Brotons, Michael E Farkouh, Valentin Fuster, None, A Polypill Strategy to Improve Adherence: Results From the FOCUS Project Journal of the American College of Cardiology. ,vol. 64, pp. 2071- 2082 ,(2014) , 10.1016/J.JACC.2014.08.021
Daniel S Streetman, John D Piette, Michele Heisler, James G Stevenson, Hae Mi Choe, Connie J Sandiford, Impact of patient financial incentives on participation and outcomes in a statin pill-splitting program. The American Journal of Managed Care. ,vol. 13, pp. 298- 304 ,(2007)
Cyndee H Yonehara, Diane G Ditmer, Amy C Waterbury, Andrew Williams, Reesa Laws, David H Smith, Jeffrey O Tom, Jennifer L Schneider, William M Vollmer, Suma Vupputuri, Ashil A Owen-Smith, Cynthia S Rand, Improving adherence to cardiovascular disease medications with information technology The American Journal of Managed Care. ,vol. 20, ,(2014)
Karen A Grace, Jeannie K Lee, Terri G Foster, Phuong T Turner, Monica J Crawley, Hazel J Sun, Lance E Sullenberger, Goldina I Erowele, Allen J Taylor, How should we measure medication adherence in clinical trials and practice Therapeutics and Clinical Risk Management. ,vol. 3, pp. 685- 690 ,(2007)
Etienne IJJ Vermeire, Johan Wens, Paul Van Royen, Yves Biot, Hilary Hearnshaw, Antje Lindenmeyer, Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus Cochrane Database of Systematic Reviews. pp. 39- ,(2005) , 10.1002/14651858.CD003638.PUB2
Robby Nieuwlaat, Nancy Wilczynski, Tamara Navarro, Nicholas Hobson, Rebecca Jeffery, Arun Keepanasseril, Thomas Agoritsas, Niraj Mistry, Alfonso Iorio, Susan Jack, Bhairavi Sivaramalingam, Emma Iserman, Reem A Mustafa, Dawn Jedraszewski, Chris Cotoi, R. Brian Haynes, Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews. ,vol. 2014, ,(2008) , 10.1002/14651858.CD000011.PUB4
Elísio Costa, Sergio Pecorelli, Anna Giardini, Magda Savin, Enrica Menditto, Elaine Lehane, Olga Laosa, Alessandro Monaco, Alessandra Marengoni, Interventional tools to improve medication adherence: review of literature Patient Preference and Adherence. ,vol. 9, pp. 1303- 1314 ,(2015) , 10.2147/PPA.S87551